UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

In 1957, when the British psychiatrist Humprhey Osmond was looking to coin a word for the mind-bending effects of LSD, he wrote a letter to his friend Aldous Huxley. The "Brave New World" author — who ...

The findings of the first study ever on how LSD (lysergic acid diethylamide) affects the brain have been released and its results might help LSD join ketamine a.k.a. "special K" as a treatment for ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

Dropping acid can allay angst in those suffering terminal illness, a new survey has exposed. Noting that legalized used of LSD by U.S. psychiatrists slammed to a halt in 1966 after the mind-altering ...

Would you pay money to support a scientific experiment involving illegal drugs? A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) ...

A new study published last month examined the influence of LSD on brain connections, yielding some enlightening results. The study, published in the Journal of Psychopharmacology, found that the “drug ...

(CNN) — A clinical trial’s encouraging results won an LSD formulation approval from the US Food and Drug Administration as a breakthrough therapy for generalized anxiety disorder, Mind Medicine Inc.

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

BASEL, Switzerland, Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD neutralizer ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

BASEL, Switzerland, Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD neutralizer ...